Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-045295
Filing Date
2024-11-14
Accepted
2024-11-14 06:23:41
Documents
95
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1444581
2 ex10-1.htm EX-10.1 1509601
3 ex31-1.htm EX-31.1 18386
4 ex31-2.htm EX-31.2 18331
5 ex32-1.htm EX-32.1 9160
  Complete submission text file 0001493152-24-045295.txt   10281937

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hrow-20240930.xsd EX-101.SCH 59893
7 XBRL CALCULATION FILE hrow-20240930_cal.xml EX-101.CAL 87173
8 XBRL DEFINITION FILE hrow-20240930_def.xml EX-101.DEF 327112
9 XBRL LABEL FILE hrow-20240930_lab.xml EX-101.LAB 481414
10 XBRL PRESENTATION FILE hrow-20240930_pre.xml EX-101.PRE 423475
98 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1506848
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 241456929
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)